Panos Konstantinopoulos, MD, PhD shares results of a phase 2 endometrial cancer study at 2022 SGO.
2 بازدیدها
administrator
07/17/23
Panos Konstantinopoulos, MD, PhD shares results of a phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer at the 2022 Society for Gynecologic Oncology Annual Meeting.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
نظری یافت نشد